Wells Fargo’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Buy |
|
|||||
|
2025
Q1 | $81.3K | Buy |
|
|||||
|
2024
Q4 | $152K | Buy |
|
|||||
|
2024
Q3 | $207K | Buy |
|
|||||
|
2024
Q2 | $188K | Buy |
|
|||||
|
2024
Q1 | $301K | Buy |
|
|||||
|
2023
Q4 | $143K | Buy |
|
|||||
|
2023
Q3 | $72.7K | Sell |
|
|||||
|
2023
Q2 | $1.01M | Sell |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $511K | Buy |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | $1.13M | Sell |
|
|||||
|
2022
Q1 | $5.52M | Sell |
|
|||||
|
2021
Q4 | $10.7M | Sell |
|
|||||
|
2021
Q3 | $22.6M | Buy |
|
|||||
|
2021
Q2 | $28.4M | Buy |
|
|||||
|
2021
Q1 | $17.1M | Sell |
|
|||||
|
2020
Q4 | $20.7M | Sell |
|
|||||
|
2020
Q3 | $9.91M | Sell |
|
|||||
|
2020
Q2 | $11.8M | Sell |
|
|||||
|
2020
Q1 | $9.41M | Sell |
|
|||||
|
2019
Q4 | $9.77M | Buy |
|
|||||
|
2019
Q3 | $7.04M | Sell |
|
|||||
|
2019
Q2 | $9.72M | Buy |
|
|||||
|
2019
Q1 | $2.48M | Sell |
|
|||||
|
2018
Q4 | $2.08M | Sell |
|
|||||
|
2018
Q3 | $3.09M | Buy |
|
|||||
|
2018
Q2 | $1.33M | Buy |
|
|||||
|
2018
Q1 | $1.02M | Sell |
|
|||||
|
2017
Q4 | $2M | Buy |
|
|||||
|
2017
Q3 | $965K | Sell |
|
|||||
|
2017
Q2 | $820K | Sell |
|
|||||
|
2017
Q1 | $1.28M | Buy |
|
|||||
|
2016
Q4 | $69K | Buy |
|
|||||
|
2016
Q3 | $83K | Buy |
|
|||||
|
2016
Q2 | $2K | Hold |
|
|||||
|
2016
Q1 | $2K | Hold |
|
|||||
|
2015
Q4 | $3K | Hold |
|
|||||
|
2015
Q3 | $5K | Sell |
|
|||||
|
2015
Q2 | $13K | Hold |
|
|||||
|
2015
Q1 | $10K | Hold |
|
|||||
|
2014
Q4 | $10K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $97K | Buy |
|